Publications (original articles or review articles) published in 2022 from OUS - Section for Preventive Cardiology
10 publications found
Do we need new lipid-lowering agents in the era of PCSK9 inhibitors? Recent advances
Kardiol Pol, 80 (7-8), 741-749
DOI 10.33963/KP.a2022.0117, PubMed 35521719
Randomized trial of cardiovascular prevention in Norway combining an in-hospital lifestyle course with primary care follow-up: the Hjerteløftet study
Eur J Prev Cardiol, 29 (17), 2252-2263
DOI 10.1093/eurjpc/zwac211, PubMed 36124709
The Effect of Smoking Cessation on Body Weight and Other Metabolic Parameters with Focus on People with Type 2 Diabetes Mellitus
Int J Environ Res Public Health, 19 (20)
DOI 10.3390/ijerph192013222, PubMed 36293800
Vegetarian and vegan diets and the risk of cardiovascular disease, ischemic heart disease and stroke: a systematic review and meta-analysis of prospective cohort studies
Eur J Nutr, 62 (1), 51-69
DOI 10.1007/s00394-022-02942-8, PubMed 36030329
Effect of smoking cessation on cardiac troponin I concentrations
Scand J Clin Lab Invest, 82 (2), 104-107
DOI 10.1080/00365513.2022.2031277, PubMed 35112632
Tobacco and nicotine use
Nat Rev Dis Primers, 8 (1), 19
DOI 10.1038/s41572-022-00346-w, PubMed 35332148
Quality of clinical management of cardiometabolic risk factors in patients with severe mental illness in a specialist mental health care setting
Nord J Psychiatry, 76 (8), 602-609
DOI 10.1080/08039488.2022.2039288, PubMed 35200088
High levels of lipoprotein(a) - assessment and treatment
Tidsskr Nor Laegeforen, 142 (1)
DOI 10.4045/tidsskr.21.0800, PubMed 36655975
Medication-assisted quit rates in participants with smoking-related diseases in EAGLES: Post hoc analyses of a double-blind, randomized, placebo-controlled clinical trial
Tob Induc Dis, 20, 46
DOI 10.18332/tid/146567, PubMed 35611069
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Eur J Prev Cardiol, 29 (1), 5-115
DOI 10.1093/eurjpc/zwab154, PubMed 34558602